Home › Funds › Eagle Health Investments LP › IONS
Eagle Health Investments LP position in IONS
IONIS PHARMACEUTICALS INC · Health Care
Eagle Health Investments LP reported holding 194,577 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$15.4M, representing 2.56% of its reported portfolio and ranking #18 among its reported holdings. Eagle Health Investments LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's IONS position evolved
Eagle Health Investments LP first disclosed a stake in IONS in Q2 2026 at 194,577 shares (US$15.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 194.58K | $15.43M | New |
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M sh · $180.81M · Q2 2026
- Deep Track Capital, LP 2.20M sh · $174.44M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K sh · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K sh · $52.70M · Q2 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held IONS?
Eagle Health Investments LP has disclosed IONS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Eagle Health Investments LP's current position in IONS?
As of Q2 2026, Eagle Health Investments LP holds 194.58K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $15.43M, representing 2.56% of its reported portfolio and ranking #18.
Has Eagle Health Investments LP been buying or selling IONS?
In the latest 13F filing (Q2 2026), Eagle Health Investments LP newly opened its position in IONS.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.